James Brumley
James Brumley (RSS)
InvestorPlace Contributor

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He's now primarily a freelance writer, tapping more than a decade's worth of broad experience to help investors get more out of the market.

Read complete bio
Recent Articles

Is Z Stock Worth Owning After the Zillow Earnings Report?

Nov. 7, 2014, 8:58 am EST – The market dumped Z stock after the Zillow earnings announcement, but only because they lost sight of the bigger picture. More 

Why Zulily Inc, SolarCity Corp and Stratasys, Ltd. Are Today’s 3 Worst Stocks

Nov. 5, 2014, 4:44 pm EST – Zulily Inc, SolarCity Corp and Stratasys, Ltd. are Wednesday's biggest losers. Shareholders (current or potential) of these names may want to find out why. More 

The First Santa Claus Rally Reality Check of 2014

Nov. 5, 2014, 9:14 am EST – The Santa Claus rally discussion surfaces every year, and 2014 won't be any different. But this year, let's put the premise to the test before pulling the trigger. More 

Can the Swiss Single-Handedly Buoy Gold Prices?

Nov. 5, 2014, 9:07 am EST – Gold prices have been falling rapidly of late, but some Swiss say it's still a must-have asset for its central bank. More 

4 Small-Cap Stocks to Buy

Nov. 5, 2014, 6:00 am EST – Looking for stocks to buy that aren't frighteningly overbought? Start the search with these four undervalued and underestimated small-cap stocks. More 

Apple Pay Versus CurrentC: Which is Built to Last?

Oct. 31, 2014, 2:44 pm EST – Apple Pay, Softcard, CurrentC and Google Wallet -- this fragmentation can't last forever. Here's the handicap of the race. More 

Is Google Stock Becoming a Healthcare Stock?

Oct. 30, 2014, 2:01 pm EST – Google stock isn't likely to ever predominantly be a healthcare stock, but that's not to say healthcare won't be a key piece of its revenue. More 

MNKD: 17 Weeks and 58% Later, MannKind Stock FINALLY Is a Buy

Oct. 28, 2014, 12:15 pm EST – MannKind Corporation (MNKD) has disappointed a lot of investors since Afrezza was approved in June, but the tide is finally turning for MannKind stock. More 

Facebook Earnings: What to Know Before Tuesday’s Report (FB)

Oct. 27, 2014, 10:21 am EST – Any fans and followers of FB stock have a few things to think about before Q3 Facebook earnings figures are posted Tuesday afternoon. More 

Mid-Caps Fell Off the Radar. Big Mistake.

Oct. 23, 2014, 1:12 pm EST – Mid-caps have been outperforming other areas for five years now, and deservedly so. Here's why, and why that leadership isn't about to falter. More